H. Chen, G. Smith, K. Li, J. Wang, and X. Fan, Establishment of multiple sublineages of H5N1 influenza virus in Asia: Implications for pandemic control, Proceedings of the National Academy of Sciences, vol.103, issue.8, pp.2845-2850, 2006.
DOI : 10.1073/pnas.0511120103

R. Webster, M. Peiris, H. Chen, and Y. Guan, H5N1 outbreaks and enzootic influenza, Biodiversity, vol.56, issue.1, pp.3-8, 2006.
DOI : 10.1080/14888386.2006.9712795

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291402

G. Smith, X. Fan, J. Wang, K. Li, and K. Qin, Emergence and predominance of an H5N1 influenza variant in China, Proceedings of the National Academy of Sciences, vol.103, issue.45, pp.16936-16941, 2006.
DOI : 10.1073/pnas.0608157103

R. Gutierrez, M. Naughtin, S. Horn, S. San, and P. Buchy, A(H5N1) Virus Evolution in South East Asia, Viruses, vol.1, issue.3, pp.335-361, 2009.
DOI : 10.3390/v1030335

URL : https://hal.archives-ouvertes.fr/pasteur-00808147

J. Bresson, C. Perronne, O. Launay, C. Gerdil, and M. Saville, Safety and immunogenicity of an inactivated split-virion influenza A/VietnamH5N1) vaccine: phase I randomised trial, Lancet, vol.1194, issue.367, pp.1657-1664, 2004.

J. Lin, J. Zhang, X. Dong, H. Fang, and J. Chen, Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial, The Lancet, vol.368, issue.9540, pp.991-997, 2006.
DOI : 10.1016/S0140-6736(06)69294-5

X. Lu, L. Edwards, J. Desheva, D. Nguyen, and A. Rekstin, Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses, Vaccine, vol.24, issue.44-46, pp.6588-6593, 2006.
DOI : 10.1016/j.vaccine.2006.05.039

G. Rimmelzwaan, E. Claas, G. Van-amerongen, J. De-jong, and A. Osterhaus, ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus, Vaccine, vol.17, issue.11-12, pp.1355-1358, 1999.
DOI : 10.1016/S0264-410X(98)00390-9

J. Treanor, J. Campbell, K. Zangwill, T. Rowe, and M. Wolff, Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine, New England Journal of Medicine, vol.354, issue.13, pp.1343-1351, 2006.
DOI : 10.1056/NEJMoa055778

K. Subbarao and T. Joseph, Scientific barriers to developing vaccines against avian influenza viruses, Nature Reviews Immunology, vol.23, issue.4, pp.267-278, 2007.
DOI : 10.1038/nri2054

H. Song, G. Nieto, and D. Perez, A New Generation of Modified Live-Attenuated Avian Influenza Viruses Using a Two-Strategy Combination as Potential Vaccine Candidates, Journal of Virology, vol.81, issue.17, pp.9238-9248, 2007.
DOI : 10.1128/JVI.00893-07

T. Horimoto and Y. Kawaoka, Strategies for developing vaccines against H5N1 influenza A viruses, Trends in Molecular Medicine, vol.12, issue.11, pp.506-514, 2006.
DOI : 10.1016/j.molmed.2006.09.003

W. Gao, A. Soloff, X. Lu, A. Montecalvo, and D. Nguyen, Protection of Mice and Poultry from Lethal H5N1 Avian Influenza Virus through Adenovirus-Based Immunization, Journal of Virology, vol.80, issue.4, pp.1959-1964, 2006.
DOI : 10.1128/JVI.80.4.1959-1964.2006

M. Hoelscher, S. Garg, D. Bangari, J. Belser, and X. Lu, Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice, The Lancet, vol.367, issue.9509, pp.475-481, 2006.
DOI : 10.1016/S0140-6736(06)68076-8

M. Bublot, N. Pritchard, J. Cruz, T. Mickle, and P. Selleck, Efficacy of a Fowlpox-Vectored Avian Influenza H5 Vaccine Against Asian H5N1 Highly Pathogenic Avian Influenza Virus Challenge, Avian Diseases, vol.51, issue.s1, pp.498-500, 2007.
DOI : 10.1637/7624-042706R.1

A. Bukreyev, Z. Huang, L. Yang, S. Elankumaran, and M. St-claire, Recombinant Newcastle Disease Virus Expressing a Foreign Viral Antigen Is Attenuated and Highly Immunogenic in Primates, Journal of Virology, vol.79, issue.21, pp.13275-13284, 2005.
DOI : 10.1128/JVI.79.21.13275-13284.2005

R. Bright, D. Carter, C. Crevar, F. Toapanta, and J. Steckbeck, Cross-Clade Protective Immune Responses to Influenza Viruses with H5N1 HA and NA Elicited by an Influenza Virus-Like Particle, PLoS ONE, vol.305, issue.1, p.1501, 2008.
DOI : 10.1371/journal.pone.0001501.t004

F. Quan, C. Huang, R. Compans, and S. Kang, Virus-Like Particle Vaccine Induces Protective Immunity against Homologous and Heterologous Strains of Influenza Virus, Journal of Virology, vol.81, issue.7, pp.3514-3524, 2007.
DOI : 10.1128/JVI.02052-06

C. Crevar and T. Ross, Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine, Virology Journal, vol.5, issue.1, p.131, 2008.
DOI : 10.1128/JVI.01460-06

K. Mahmood, R. Bright, N. Mytle, D. Carter, and C. Crevar, H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses, Vaccine, vol.26, issue.42, pp.5393-5399, 2008.
DOI : 10.1016/j.vaccine.2008.07.084

S. Kang, D. Yoo, A. Lipatov, J. Song, and C. Davis, Induction of long-term protective immune responses by influenza H5N1 virus-like particles. PLoS One, 2009.
DOI : 10.1371/journal.pone.0004667

URL : http://doi.org/10.1371/journal.pone.0004667

L. Perrone, A. Ahmad, V. Veguilla, X. Lu, and G. Smith, Intranasal Vaccination with 1918 Influenza Virus-Like Particles Protects Mice and Ferrets from Lethal 1918 and H5N1 Influenza Virus Challenge, Journal of Virology, vol.83, issue.11, pp.5726-5734, 2009.
DOI : 10.1128/JVI.00207-09

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2681940

J. Szécsi, B. Boson, P. Johnsson, P. Dupeyrot-lacas, and M. Matrosovich, Induction of neutralising antibodies by virus-like particles harbouring surface proteins from highly pathogenic H5N1 and H7N1 influenza viruses, Virology Journal, vol.3, issue.1, p.70, 2006.
DOI : 10.1186/1743-422X-3-70

R. Bright, T. Ross, K. Subbarao, H. Robinson, and J. Katz, Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine, Virology, vol.308, issue.2, pp.270-278, 2003.
DOI : 10.1016/S0042-6822(03)00008-4

S. Epstein, T. Tumpey, J. Misplon, C. Lo, and L. Cooper, DNA Vaccine Expressing Conserved Influenza Virus Proteins Protective Against H5N1 Challenge Infection in Mice, Emerging Infectious Diseases, vol.8, issue.8, pp.796-801, 2002.
DOI : 10.3201/eid0805.010476

P. Lalor, R. Webby, J. Morrow, D. Rusalov, and D. Kaslow, Plasmid DNA?based vaccines protect mice and ferrets against lethal challenge with A/ Vietnam (H5N1) influenza virus, J Infect Dis, vol.197, pp.4-1643, 1203.

M. Sharpe, D. Lynch, S. Topham, D. Major, and J. Wood, Protection of mice from H5N1 influenza challenge by prophylactic DNA vaccination using particle mediated epidermal delivery, Vaccine, vol.25, issue.34, pp.6392-6398, 2007.
DOI : 10.1016/j.vaccine.2007.06.009

S. Rao, W. Kong, C. Wei, Z. Yang, and M. Nason, Multivalent HA DNA Vaccination Protects against Highly Pathogenic H5N1 Avian Influenza Infection in Chickens and Mice, PLoS ONE, vol.310, issue.6, p.2432, 2008.
DOI : 10.1371/journal.pone.0002432.s003

URL : http://doi.org/10.1371/journal.pone.0002432

M. Chen, T. Cheng, Y. Huang, J. Jan, and S. Ma, A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses, Proceedings of the National Academy of Sciences, vol.105, issue.36, pp.13538-13543, 2008.
DOI : 10.1073/pnas.0806901105

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2533225

L. Smith, M. Wloch, M. Ye, L. Reyes, and S. Boutsaboualoy, Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin, Vaccine, vol.28, issue.13, pp.2565-2572, 2010.
DOI : 10.1016/j.vaccine.2010.01.029

E. Hoffmann, A. Lipatov, R. Webby, E. Govorkova, and R. Webster, Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines, Proceedings of the National Academy of Sciences, vol.102, issue.36, pp.12915-12920, 2005.
DOI : 10.1073/pnas.0506416102

Z. Yang, C. Wei, W. Kong, L. Wu, and L. Xu, Immunization by Avian H5 Influenza Hemagglutinin Mutants with Altered Receptor Binding Specificity, Science, vol.317, issue.5839, pp.825-828, 2007.
DOI : 10.1126/science.1135165

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2367145

B. Zhou, N. Zhong, and Y. Guan, Treatment with Convalescent Plasma for Influenza A (H5N1) Infection, New England Journal of Medicine, vol.357, issue.14, pp.1450-1451, 2007.
DOI : 10.1056/NEJMc070359

P. Buchy, S. Mardy, S. Vong, T. Toyoda, and J. Aubin, Influenza A/H5N1 virus infection in humans in Cambodia, Journal of Clinical Virology, vol.39, issue.3, pp.164-168, 2007.
DOI : 10.1016/j.jcv.2007.04.010

URL : https://hal.archives-ouvertes.fr/hal-00167807

L. Reed and H. Muench, A simple method of estimating fifty percent endpoints, Am J Hyg, vol.27, pp.493-497, 1938.

R. Zufferey, D. Nagy, R. Mandel, L. Naldini, and D. Trono, Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo, Nature Biotechnology, vol.88, issue.9, pp.871-875, 1997.
DOI : 10.1038/nbt0997-871

L. Naldini, U. Blömer, P. Gallay, D. Ory, and R. Mulligan, In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector, Science, vol.272, issue.5259, pp.263-267, 1996.
DOI : 10.1126/science.272.5259.263

C. Tsai, C. Caillet, H. Hu, F. Zhou, and H. Ding, Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase, Vaccine, vol.27, issue.48, pp.6777-6790, 2009.
DOI : 10.1016/j.vaccine.2009.08.056

URL : https://hal.archives-ouvertes.fr/pasteur-00625272

I. Ramshaw and A. Ramsay, The prime-boost strategy: exciting prospects for improved vaccination, Immunology Today, vol.21, issue.4, pp.163-165, 2000.
DOI : 10.1016/S0167-5699(00)01612-1

D. Ikeno, K. Kimachi, Y. Kudo, S. Goto, and S. Itamura, A prime???boost vaccination of mice with heterologous H5N1 strains, Vaccine, vol.27, issue.23, pp.3121-3125, 2009.
DOI : 10.1016/j.vaccine.2009.01.007

C. Lo, Z. Wu, J. Misplon, G. Price, and C. Pappas, Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: Cold-adapted vaccine versus DNA prime-adenovirus boost strategies, Vaccine, vol.26, issue.17, pp.2062-2072, 2008.
DOI : 10.1016/j.vaccine.2008.02.047

S. Wang, C. Parker, J. Taaffe, A. Solórzano, and A. García-sastre, Heterologous HA DNA vaccine prime???inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses, Vaccine, vol.26, issue.29-30, pp.3626-3633, 2008.
DOI : 10.1016/j.vaccine.2008.04.073

M. Steensels, M. Bublot, V. Borm, S. , D. Vriese et al., Prime???boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI, Vaccine, vol.27, issue.5, pp.646-654, 2009.
DOI : 10.1016/j.vaccine.2008.11.044

Z. Pan, X. Zhang, S. Geng, Q. Fang, and M. You, Prime-Boost Immunization Using a DNA Vaccine Delivered by Attenuated Salmonella enterica Serovar Typhimurium and a Killed Vaccine Completely Protects Chickens from H5N1 Highly Pathogenic Avian Influenza Virus, Clinical and Vaccine Immunology, vol.17, issue.4, pp.518-523, 2010.
DOI : 10.1128/CVI.00387-09

N. Sabarth, M. Howard, H. Savidis-dacho, A. Van-maurik, and P. Barrett, Comparison of single, homologous prime-boost and heterologous prime-boost immunization strategies against H5N1 influenza virus in a mouse challenge model, Vaccine, vol.28, issue.3, pp.650-656, 2010.
DOI : 10.1016/j.vaccine.2009.10.105

A. Gonzalez-fernandez and C. Milstein, Low antigen dose favours selection of somatic mutants with hallmarks of antibody affinity maturation, Immunology, vol.14, issue.2, pp.149-153, 1998.
DOI : 10.1046/j.1365-2567.1998.00423.x

A. Bot, S. Antohi, and C. Bona, Immune response of neonates elicited by somatic transgene vaccination with naked DNA, Front Biosci, vol.2, pp.173-188, 1997.